Download presentation
Presentation is loading. Please wait.
1
NUCLEOTIDE METABOLISM Metabolism of pyrimidine nucleotides
Prof. Mária Sasvári NUCLEOTIDE METABOLISM Metabolism of pyrimidine nucleotides Gergely Keszler 2009.
2
The structure of nucleobases
N-containing, heterocyclic aromatic compounds; substituted purine or pyrimidine rings RNA DNA
3
Pyrimidine nucleotides
“de novo” synthesis BLOOD Catabolism cytidine uridine CTP UTP CMP UMP PRPP salvage reactions dTTP CO2, NH3, b-alanine CoA
4
PYRIMIDINE nucleotide synthesis
“de novo” synthesis UTP UDP UMP CTP salvage reactions nucleosides UMP-S Py 5,6 OA H2OA mito Py 4 Asp Gln CO2 CAD Py 1-3
5
“de novo” PYRIMIDINE synthesis
CO2 1. Glu Gln 2 ATP 2 ADP + Pi Carbamoyl-P synthetase II (CPSII) C Py1 NH2 C O O - P carbamoyl-P 2. Asp Asp transcarbamoylase A Py2
6
“de novo” PYRIMIDINE synthesis
NH2 C O N H carbamoyl-Asp COO- COO - 3. Dihydroorotase D Py3 H2O HN O N H Dihydroorotate (H2OA) COO-
7
“de novo” PYRIMIDINE synthesis
OA “de novo” PYRIMIDINE synthesis NAD+ 4. Dihydroorotate dehydrogenase NADH + H+ Py4 HN O N H orotate (OA) COO-
8
“de novo” PYRIMIDINE synthesis phosphoribosyl transferase
5. PPi PRPP Orotate phosphoribosyl transferase UMP-S (synthase) Py5 Py6 HN O N COO- R- P Orotidylate (OMP) 6. OMP decarboxylase CO2 UMP
9
Pyrimidine monophosphate Pyrimidine diphosphate
UTP UDP UMP CTP UMP UDP ADP ATP 7. Pyrimidine monophosphate kinase ADP ATP UTP (2,4-dioxo) 8. Pyrimidine diphosphate kinase Glu Gln CTP (2-oxo-4 amino) 9. CTP synthetase ADP ATP
10
PYRIMIDINE “de novo” synthesis
Regulation of PYRIMIDINE “de novo” synthesis CAD Py 1-3 CAD complex: a single polypeptide three active centers + allosteric sites UTP PRPP + UMP
11
Comparison of CPS I and II isoenzymes
CPSI CPSII • role urea cycle de novo pyrimidine biosynthesis • localization mitochondrial cytosolic • N-donor free NH glutamine • regulation + N-acetyl-glutamate PRPP, - UTP
12
Orotic aciduria 1. UMP-S deficiency Main reasons of orotic aciduria
treatment: oral uridine 2. Inhibition of UMP-S Allopurinol treatment (gout) 6-azauridine treatment (tumor) 3. Ornitine transcarbamoylase deficiency (urea cycle): NH3 CP Type II hyperammonemia, carbamoyl P (CP) accumulation CAD can use the leaking CP orotic acid overproduction orotic aciduria
13
Nucleoside nucleotide Uridine/cytidine kinase
SALVAGE Nucleoside nucleotide citidin uridin CMP UMP B r uridine cytidine ATP ADP ATP ADP Uridine/cytidine kinase B r -p UMP CMP Cytidylate deaminase H2O NH3
14
Nucleotide Nucleoside
CATABOLISM Nucleotide Nucleoside cytidine uridine CMP UMP B r -p UMP (TMP) CMP 5’nucleotidase B r Pi uridine (thymidine) cytidine cytidine deaminase H2O NH3
15
cytidine deaminase pyrimidine nucleoside phosphorylase dihydropyrimidine dehydrogenase dihydropyrimidinase ureidopropionase Coenzyme A
16
ribonucleotide reductase enzyme
Formation of deoxynucleotides NADP+ NADPH + H+ H2O β-D-ribofuranose (in RNA) 2’-deoxy-β-D-ribofuranose (in DNA) In cells, deoxyribonucleotides are synthesised from ribonucleotides by the ribonucleotide reductase enzyme
17
The ribonucleotide reductase reaction (RR)
NDP dNDP NDP: UDP/ADP/GDP/CDP H2O RR S SH TR S SH TR: thioredoxin reductase or: glutaredoxin reductase (glutathion) FADH2 FAD NADPH+ H+ NADP+
18
Mechanism of the RR reaction
ribonucleotide reductase
19
constitutive expression RR is active in dividing cells!
The RR is a dimer R1 – catalytic subunit constitutive expression R2 – regulatory subunit induced in the S-phase RR is active in dividing cells!
20
Allosteric REGULATION
1. dATP: complete inhibition 2. Regulation of the ratio Substrates: CDP UDP GDP ADP Products: dCTP dTTP dGTP dATP + + dCDP dUDP dUMP
21
Synthesis of thymine nucleotides
UMP UDP dUDP dUDP dTTP DNA Folate antagonists (chemotherapy!)
22
5-FU, a potent inhibitor of thymidylate
synthase 5-fluoro-uracil (5-FU) inhibitor of thymine synthesis – WHY?? used to treat solid tumors (pancreas, lung, colon)
23
Inhibition of the folate synthesis: antibacterial effect
Human: folic acid is a vitamin Bacteria: synthesis of folate can be selectively inhibited folic acid sulphonamides
24
The role of folate and vitamin B12 in DNA synthesis and cell division
oxidative stress atherosclerosis adenosine THF CH3-THF HomoCys Gly Ser SAM SAH -CH3 folate cycle B12 SAM/SAH cycle CH2-THF dUMP dTMP purine synthesis Cell division Met “methyl trap” B12/folate deficiency: pernicious anemia
25
Folate deficiency – megaloblastic anemia
26
Vitamin B12 (cobalamin) deficiency Methylmalonic aciduria
might be due to achlorhydria (chronic gastritis, no IF production) treatment: parenteral administration of B12 Methylmalonic aciduria Megaloblastic anemia (Pernicious anemia) nerve degeneration paralysis and death (B12 is needed for myelin synthesis) Anemia is due to impaired dTTP synthesis for DNA replication in hematopoetic precursor cells
27
“Salvage” reaction of deoxynucleosides
Thymidine kinase (dTK) dThd dTMP ATP ADP Deoxycytidine kinase (dCK) dCyd dCMP lymphoid specific ATP ADP Broad substrate specificity Substrates: dAdo, dGuo, dCyd Analogues of deoxynucleotides: antileukemic agents purine and pyrimidine analogues
28
2-chloro-2’-deoxyadenosine Hairy cell leukemia (HCL)
Purine analogues 6-mercaptopurine 8-azaguanine 2-chloro-2’-deoxyadenosine (CdA, Cladribine®) Hairy cell leukemia (HCL)
29
(araC; for treating AML)
Pyrimidine analogues containing sugar derivatives 2’-deoxy-2’, 2’- -difluorocytidine (dFdC, Gemcitabine) 2’, 3’-dideoxy-cytidine arabinosyl-cytosine (araC; for treating AML)
30
“Salvage” reaction of deoxynucleosides
Thymidine kinase (dTK) dThd dTMP ATP ADP S-phase dependent enzyme Human dTK: narrow substrate specificity Herpes Simplex Virus : HSV- dTK: wide substrate specificity Antiviral medication (Acyclovir) Suicide gene therapy (Gancyclovir, AIDS)
31
inhibition of viral DNA (RNA) replication
Antiviral nucleoside analogues Acyclovir Stavudine Didanosine 9-hydroxyethoxy- methyl guanine, an acyclic nucleoside inhibition of viral DNA (RNA) replication herpes viruses, HIV inhibitors of retroviral reverse transcriptase
32
purine- pyrimidine nucleotides origin of the atoms in the ring
„de novo” synthesis of purine pyrimidine nucleotides „free” (no sugar) purine/pyrimidine ring containing intermedier NO YES (orotic acid) PRPP is an allosteric activator YES YES C1-TH4 donor YES NO (except thymidine!) role of Asp N donor incorporates origin of amino groups Asp, Gln Gln origin of the atoms in the ring Gly, Asp, Gln, C1-THF, CO2 Asp CO2, NH3 (Gln, Glu)
33
purine- pyrimidine nucleotides
„salvage” pathway of purine pyrimidine nucleotides mainly from bases through PRPP reaction YES NO PRPP is necessary YES NO mainly from nucleosides NO YES
34
purine- pyrimidine nucleotides
Catabolic pathway of purine pyrimidine nucleotides N of rings will be excreted YES NO amino groups saved YES YES diseases hyperuricemia orotic aciduria
Similar presentations
